Carbinoxamine tannate 0.64 mg/mL / dextromethorphan tannate 5.5 mg/mL / pseudoephedrine tannate 9.04 mg/mL Extended Release Suspension
RxNorm 1012964
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1012964 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: carbinoxamine tannate 0.64 mg/mL / dextromethorphan tannate 5.5 mg/mL / pseudoephedrine tannate 9.04 mg/mL Extended Release Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Carbinoxamine tannate 0.64 mg/ML / dextromethorphan tannate 5.5 mg/ML / pseudoephedrine tannate 9.04 mg/ML Extended Release Suspension
(Atom ID: 12331129)
PSN